Leap Therapeutics (LPTX) SEC Filings & 10K Form

$3.25
+0.08 (+2.52%)
(As of 04/26/2024 ET)

Recent Leap Therapeutics SEC Filings

DateFilerForm TypeView
04/25/2024
7:39 PM
Leap Therapeutics (Subject)
Samsara BioCapital, L.P. (Filed by)
Form SC 13G
04/19/2024
3:31 PM
GILEAD SCIENCES, INC. (Reporting)
Leap Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/19/2024
3:31 PM
GILEAD SCIENCES, INC. (Filed by)
Leap Therapeutics (Subject)
Form SC 13G
04/11/2024
7:42 AM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
6:41 AM
Leap Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/18/2024
6:10 AM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
5:50 AM
Leap Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/31/2024
8:34 PM
LAWLOR AUGUSTINE (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:34 PM
Leap Therapeutics (Issuer)
Martin Patricia A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:34 PM
Leap Therapeutics (Issuer)
Sirard Cynthia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:34 PM
Leap Therapeutics (Issuer)
O'Mahony John Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:35 PM
Leap Therapeutics (Issuer)
Richard Christian M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:35 PM
Baum Jason (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:35 PM
Granfield Christine (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:36 PM
Leap Therapeutics (Issuer)
Schilsky Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:36 PM
Dietz Thomas John (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:37 PM
Leap Therapeutics (Issuer)
Mashiach Nissim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:31 PM
CAVANAUGH JAMES H (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:32 PM
Leap Therapeutics (Issuer)
LI WILLIAM (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:32 PM
Leap Therapeutics (Issuer)
ONSI DOUGLAS E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:33 PM
Leap Therapeutics (Issuer)
Mirabelli Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:33 PM
Leap Therapeutics (Issuer)
LOSCALZO JOSEPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
7:37 PM
Leap Therapeutics (Issuer)
ONSI DOUGLAS E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
7:38 PM
LAWLOR AUGUSTINE (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
7:39 PM
Leap Therapeutics (Issuer)
Sirard Cynthia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
7:41 PM
Leap Therapeutics (Issuer)
O'Mahony John Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
7:42 PM
Leap Therapeutics (Issuer)
Mirabelli Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
4:28 PM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2024
4:10 PM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
6:10 AM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
5:51 AM
Leap Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/13/2023
1:44 PM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2023
3:30 PM
Leap Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/25/2023
3:30 PM
Leap Therapeutics (Issuer)
LOSCALZO JOSEPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2023
3:30 PM
Leap Therapeutics (Issuer)
Sirard Cynthia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2023
3:30 PM
Baum Jason (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2023
3:30 PM
Leap Therapeutics (Issuer)
O'Mahony John Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2023
3:30 PM
Granfield Christine (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2023
3:30 PM
CAVANAUGH JAMES H (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2023
3:30 PM
Leap Therapeutics (Issuer)
Schilsky Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2023
3:30 PM
Leap Therapeutics (Issuer)
ONSI DOUGLAS E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Claim Your Complimentary Bitcoin Reward (Ad)

Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.

Secure Your Spot Now
08/25/2023
3:31 PM
Leap Therapeutics (Issuer)
Mirabelli Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2023
3:31 PM
Leap Therapeutics (Issuer)
Richard Christian M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2023
3:31 PM
Leap Therapeutics (Issuer)
Mashiach Nissim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2023
3:31 PM
LAWLOR AUGUSTINE (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2023
3:31 PM
Leap Therapeutics (Issuer)
Martin Patricia A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2023
3:31 PM
Leap Therapeutics (Issuer)
LI WILLIAM (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2023
3:31 PM
Dietz Thomas John (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2023
6:10 AM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2023
5:50 AM
Leap Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/12/2023
6:10 AM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2023
4:15 PM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2023
4:26 PM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2023
11:15 PM
Leap Therapeutics (Filer)
Form EFFECT
06/14/2023
3:31 PM
Leap Therapeutics (Filer)
Form 424B3
05/25/2023
4:18 PM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2023
6:06 AM
Leap Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/15/2023
5:50 AM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:LPTX) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners